Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C4orf46 pseudogene 1 (abbreviated C4orf46P1) is annotated as a pseudogene and does not encode a functional protein product[3]. Pseudogenes are DNA segments similar to normal genes but typically nonfunctional due to mutations, lack of promoter activity, or other disabling features. There is no evidence that C4orf46P1 acts as a therapeutic target, biomarker, or is implicated in disease or drug interactions[3]. Its naming and annotation are correct as a pseudogene, but it should not be considered a classical drug target like receptors, enzymes, or transporters.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C4orf46 pseudogene 1 (C4orf46P1).